018620 — WooGene B&G Co Share Price
Last trade - 00:00- KR₩31bn
- KR₩88bn
- KR₩58bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.97 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.54 | ||
| EV to EBITDA | 17.43 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.13% | ||
| Return on Equity | -2% | ||
| Operating Margin | 1.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 32,558.9 | 39,524.38 | 39,347.39 | 43,703.47 | 57,919.35 | n/a | n/a | 13.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
WooGene B&G Co., Ltd. is a Korea-based company mainly engaged in the manufacture of veterinary drugs. The Company’s products include anti-infective, bulk materials, probiotics, enzymes, antiparasitics, hormone preparations, vaccines, aquacultures, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, antiphlogistic injections, enhance metabolism injections, diarrhea remedy injections, sedative injections for swine, toxin binders, pigmentation drugs and others. The Company also provides anti-inflammatory enzymes under the brand name SKD, which are used for human beings. The Company distributes its products within domestic market and to overseas markets, including Iran, Vietnam, Philippines, Brazil and others.
Directors
- Jae Gu Kang CCE (44)
- Seok Jin Kang CCE (71)
- Gyeong Deok Yang VPR (59)
- Sang Yeong Lee OTH (72)
- Seong Ju Park OTH (64)
- Seung Yeop Jang NID (57)
- Jeong Tae Kim NID (58)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- December 17th, 1985
- Public Since
- May 20th, 2008
- No. of Shareholders
- 13,251
- No. of Employees
- 119
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 28,887,171
- Address
- 230, Jeongmunsongsan-ro, Yanggam-myeon, HWASEONG, 18628
- Web
- http://www.woogenebng.com/
- Phone
- +82 313520185
- Auditors
- DoOne Accounting Corporation
Upcoming Events for 018620
Similar to 018620
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
Ahn-Gook Pharmaceutical Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 24:12 UTC, shares in WooGene B&G Co are trading at KR₩1,128. This share price information is delayed by 15 minutes.
Shares in WooGene B&G Co last closed at KR₩1,128 and the price had moved by -23.33% over the past 365 days. In terms of relative price strength the WooGene B&G Co share price has underperformed the FTSE Developed Asia Pacific Index by -26.64% over the past year.
There is no consensus recommendation for this security.
WooGene B&G Co does not currently pay a dividend.
WooGene B&G Co does not currently pay a dividend.
WooGene B&G Co does not currently pay a dividend.
To buy shares in WooGene B&G Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,128, shares in WooGene B&G Co had a market capitalisation of KR₩33bn.
Here are the trading details for WooGene B&G Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 018620
Based on an overall assessment of its quality, value and momentum WooGene B&G Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like WooGene B&G Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.55%.
As of the last closing price of KR₩1,128, shares in WooGene B&G Co were trading -6.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The WooGene B&G Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,128.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
WooGene B&G Co's management team is headed by:
- Jae Gu Kang - CCE
- Seok Jin Kang - CCE
- Gyeong Deok Yang - VPR
- Sang Yeong Lee - OTH
- Seong Ju Park - OTH
- Seung Yeop Jang - NID
- Jeong Tae Kim - NID